ArticleJournal of virology2015

Dolutegravir-Selected HIV-1 Containing the N155H and R263K Resistance Substitutions Does Not Acquire Additional Compensatory Mutations under Drug Pressure That Lead to Higher-Level Resistance and Increased Replicative Capacity.

Kaitlin Anstett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.